Herold Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Herold Advisors's AMGN Position: Q1 2026 in Review
Herold Advisors reduced its Amgen (AMGN) stake by 1.3% in Q1 2026, selling an estimated $16.8K and leaving 3,624 shares worth $1.28M. The position accounts for 0.28% of the portfolio, ranked #91.
Herold Advisors first reported a position in AMGN in Q3 2021 and has held it in 16 quarters since. The position peaked at $1.71M in Q3 2024. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Herold Advisors held 3,624 shares of Amgen worth $1.28M as of Q1 2026.
- Herold Advisors sold 47 Amgen shares in Q1 2026, an estimated $16.8K.
- Amgen made up 0.28% of Herold Advisors's portfolio in Q1 2026, its #91 holding.
- Herold Advisors first reported a position in Amgen in Q3 2021 and has held it in 16 quarters since.
- Herold Advisors's Amgen position peaked at $1.71M in Q3 2024.
- 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Herold Advisors's 13F filing for Q1 2026, filed 15 May 2026.